These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28379034)

  • 1. Lipoprotein apheresis in the treatment of dyslipidaemia - the Czech Republic experience.
    Bláha V; Bláha M; Lánská M; Solichová D; Kujovská Krčmová L; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
    Physiol Res; 2017 Apr; 66(Suppl 1):S91-S100. PubMed ID: 28379034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal LDL cholesterol elimination (25 years of experience in CZ).
    Blaha M; Zadak Z; Blaha V; Andrys C; Havel E; Vyroubal P; Blazek M; Filip S; Lanska M; Maly J
    Atheroscler Suppl; 2009 Dec; 10(5):17-20. PubMed ID: 20129368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
    Blaha M; Cermanova M; Blaha V; Jarolim P; Andrys C; Blazek M; Maly J; Smolej L; Zajic J; Masin V; Zimova R; Rehacek V
    Atherosclerosis; 2008 Mar; 197(1):264-70. PubMed ID: 17540382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actual situation of lipoprotein apheresis in Saxony in 2013.
    Emmrich U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():215-25. PubMed ID: 25936329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
    Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
    Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.
    Otto C; Geiss HC; Laubach E; Schwandt P
    Ther Apher; 2002 Apr; 6(2):130-5. PubMed ID: 11982953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
    Kroon AA; van Asten WN; Stalenhoef AF
    Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of different low-density lipoprotein apheresis methods.
    Parhofer KG; Geiss HC; Schwandt P
    Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience.
    Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H
    Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.
    Keller C
    Ther Apher Dial; 2003 Jun; 7(3):345-9. PubMed ID: 12924611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.
    Kawashiri MA; Nohara A; Higashikata T; Tada H; Nakanishi C; Okada H; Konno T; Sakata K; Hayashi K; Inazu A; Mabuchi H; Yamagishi M
    Atherosclerosis; 2017 Oct; 265():225-230. PubMed ID: 28926730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
    Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
    Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Olbricht CJ; Schoeppe E
    Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
    Blaha M; Lanska M; Blaha V; Boudys L; Zak P
    Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.